Biomarkers in major depressive disorder: the role of mass spectrometry (Q38222164)

31 August 2017

title

Biomarkers in major depressive disorder: the role of mass spectrometry (English)

1 reference

major depressive disorder

31 August 2017

0 references

1 reference

Alisa G Woods

1 reference

31 August 2017

Dan V Iosifescu

series ordinal

1 reference

31 August 2017

Costel C Darie

series ordinal

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

Advances in Experimental Medicine and Biology

31 August 2017

published in

1 reference

31 August 2017

volume

806

1 reference

31 August 2017

page(s)

545-560

1 reference

Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Depression and heart disease in US adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Prevalence of depression in consecutive patients with type 2 diabetes mellitus of 5-year duration and its impact on glycemic control

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005-2008.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Cost of lost productive work time among US workers with depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Medication augmentation after the failure of SSRIs for depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: A systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Allosteric modulators of α4β2 nicotinic acetylcholine receptors: a new direction for antidepressant drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Biomarker-Based Selection of Therapy For Colorectal Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Biomarkers in psychiatry: drawbacks and potential for misuse

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Biomarkers in psychiatry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Potential biomarkers in psychiatry: focus on the cholesterol system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) tr

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Electroencephalography-derived biomarkers of antidepressant response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Microstructural Abnormalities in Subcortical Reward Circuitry of Subjects with Major Depressive Disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

The genetics of bipolar disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158)Met polymorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Interactions between early parenting and a polymorphism of the child's dopamine transporter gene in predicting future child conduct disorder symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Gene-environment interaction and suicidal behavior.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

A mega-analysis of genome-wide association studies for major depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

A comparison of selected mRNA and protein abundances in human liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Proteomic approach for the elucidation of biological defects in autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Mass spectrometry for the detection of potential psychiatric biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Mass spectrometry as a tool for studying autism spectrum disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Mass spectrometric evidence that proteolytic processing of rainbow trout egg vitelline envelope proteins takes place on the egg.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Structural characterization of fish egg vitelline envelope proteins by mass spectrometry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Isolation and structural characterization of the Ndh complex from mesophyll and bundle sheath chloroplasts of Zea mays

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Purified trout egg vitelline envelope proteins VEbeta and VEgamma polymerize into homomeric fibrils from dimers in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Blue Native PAGE and Mass Spectrometry Analysis of Ephrin Stimulation-Dependent Protein-Protein Interactions in NG108-EphB2 Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Investigation of stable and transient protein-protein interactions: Past, present, and future

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Automated mass spectrometry-based functional assay for the routine analysis of the secretome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Proteomic analysis of plasma membranes isolated from undifferentiated and differentiated HepaRG cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Disulfide proteomics for identification of extracellular or secreted proteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Automatic determination of disulfide bridges in proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

The potential of biomarkers in psychiatry: focus on proteomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Identification of potential tumor differentiation factor (TDF) receptor from steroid-responsive and steroid-resistant breast cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Identification of tumor differentiation factor (TDF) in select CNS neurons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Structural investigation of tumor differentiation factor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Proteomic research in psychiatry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Proteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Dexamethasone selectively suppresses microglial trophic responses to hippocampal deafferentation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Deafferentation-induced increases in hippocampal insulin-like growth factor-1 messenger RNA expression are severely attenuated in middle aged and aged rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Novel biomarkers in major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Decreased serum brain-derived neurotrophic factor levels in major depressed patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Neurogenesis and major depression: implications from proteomic analyses of hippocampal proteins in a rat depression model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

High-dimensional mapping of the hippocampus in depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Candidate hippocampal biomarkers of susceptibility and resilience to stress in a rat model of depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Protein and peptide profiling as a tool for biomarker discovery in depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Evaluation of a novel ELISA for serotonin: urinary serotonin as a potential biomarker for depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Human saliva proteome and transcriptome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

A two-year follow-up study of salivary cortisol concentration and the risk of depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Potential clinical utility of plasma amino acid profiling in the detection of major depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Plasma metabonomics as a novel diagnostic approach for major depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

T-lymphocyte CREB as a potential biomarker of response to antidepressant drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-06068-2_27

10.1007/978-3-319-06068-2_27

31 March 2020

Identifiers

DOI

1 reference

31 August 2017

1 reference